Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck gets EMA Committee recommendation for approval of Prevymis for prophylaxis of CMV disease in high risk adult kidney transplant recipients

Ruchika Sharma21 Oct 2023 3:02 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the Committee for Medicinal Products for Human Use (CHMP)...

Pfizer Sells ViiV Stake for USD 1.9 Billion, Shionogi Emerges Bigger Partner

USFDA nod for Pfizer Meningococcal vaccine Penbraya

Ruchika Sharma21 Oct 2023 12:30 PM IST

New York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PENBRAYA (meningococcal groups A, B, C, W and Y...

Zydus Lifesciences bags USFDA approval for type 2 diabetes mellitus drug Zituvio for adults

Ruchika Sharma21 Oct 2023 11:19 AM IST

Ahmedabad: Zydus Lifesciences Limited has announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA)...

Pfizer to set US price for COVID treatment Paxlovid at USD 1,390 per course

Ruchika Sharma20 Oct 2023 5:30 PM IST

United States: Pfizer has said it will set the U.S. price for its COVID-19 antiviral treatment Paxlovid at nearly $1,400 per five-day course when...

Ex Cipla Global CFO Kedar Upadhye appointed as new CFO of Biocon Biologics

Ruchika Sharma20 Oct 2023 2:30 PM IST

Bengaluru: Biocon Biologics Ltd, a subsidiary of Biocon Ltd has announced that the Board of Directors of Biocon Biologics have appointed Kedar Upadhye...

Natco Pharma net profit down 23.44 percent at Rs 517.9 crore in Q2

USFDA inspection: Natco Pharma gets 8 observations for Hyderabad Pharma Division

Ruchika Sharma20 Oct 2023 1:30 PM IST

Hyderabad: Natco Pharma Limited has received eight observations from the United States Food and Drug Administration (USFDA) at the end of the...

Solara Active Pharma Sciences Mangalore facility successfully completes USFDA inspection

Indoco Remedies gets 4 USFDA observations for Goa facility

Ruchika Sharma20 Oct 2023 12:30 PM IST

Mumbai: Indoco Remedies has announced that the United States Food and Drug Administration (USFDA) has concluded the pre-approval inspection with four...

Sun Pharma arm recalls 144 bottles of anti-depression medicine in US over manufacturing issue

Ruchika Sharma20 Oct 2023 11:37 AM IST

New Delhi: Drug major Sun Pharmaceutical Industries Inc has recalled 144 bottles of a generic anti-depression medicine from the US market due to...

Dabur in Controversy: Gets Rs 321 crore GST notice in India, US subsidiaries face lawsuits on allegations that hair relaxer products cause cancer

Ruchika Sharma19 Oct 2023 3:04 PM IST

Indian multinational consumer goods company, Dabur India Ltd met with twin controversies in both India and abroad, as it has received a GST Rs 321...

Expanded age indication for GSK’s AREXVY

GSK gets positive EMA Committee opinion recommending approval of Jemperli plus chemotherapy for endometrial cancer

Ruchika Sharma19 Oct 2023 2:41 PM IST

UK: GSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive...

Syngene International reports 14.22 percent increase in net profit at Rs 116.5 crore in Q2

Ruchika Sharma19 Oct 2023 1:30 PM IST

New Delhi: Syngene International Ltd has reported a 14.22 per cent increase in consolidated net profit at Rs 116.5 crore in the September quarter.The...

JnJ embarks on two year restructuring program for orthopedics business

Ruchika Sharma19 Oct 2023 12:25 PM IST

New Jersy: Johnson & Johnson has said it has embarked on a two-year restructuring program for its orthopedics business after third-quarter...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok